Skip to main content

Advertisement

Log in

Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Osteoporosis is a systemic disease with a strong genetic component. Vitamin D receptor (VDR) has been suggested as a candidate gene for osteoporosis. Therefore the present study was aimed to investigate the pattern of allelic variants of VDR gene polymorphism (FokI and BsmI), its influence on vitamin D levels and bone mineral density (BMD) in North Indian postmenopausal women with osteoporosis for possible genetic association. 254 postmenopausal osteoporotic women and 254 postmenopausal non osteoporotic women were included in the study. VDR FokI and BsmI gene polymorphism gene were assessed by the PCR-RFLP method. Serum 25-hydroxyvitamin D was measured by the ELISA. BMD at the L1–L4 lumbar spine, hip, forearm and femoral neck was assessed by dual energy X-ray absorptiometry. The average BMD at spine and hip in postmenopausal women with bb and spine, hip, femoral neck and forearm with ff genotype had significantly low BMD. The frequency of ff genotype and f allele was significantly higher in postmenopausal osteoporotic women when compared with postmenopausal non osteoporotic women. However, no significant association was found between the genotypes and vitamin D levels. Our study reveals that VDR gene FokI and BsmI polymorphism is significantly associated with low bone mineral density. Therefore the ff genotype and f allele of VDR FokI gene may be used as an important risk factor for osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 2000; 17(1):1–45.

  2. Li WF, Hou SX, Yu B, Li MM, Férec C, Chen JM. Genetics of osteoporosis: accelerating pace in gene identification and validation. Hum Genet. 2010;127(3):249–85.

    Article  CAS  Google Scholar 

  3. Osteoporosis Society of India. Action plan osteoporosis: consensus statement of an expert group. New Delhi 2003; pp 1–40.

  4. Ferrari S. Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22:723–35.

    Article  CAS  Google Scholar 

  5. Prince RL, Dick I. Oestrogen effects on calcium membrane transport: a new view of the inter-relationship between oestrogen deficiency and age-related osteoporosis. Osteoporos Int. 1997;7(Suppl 3):S150–4.

    Article  Google Scholar 

  6. van Meurs JB, Schuit SC, Weel AE, van der Klift M, Bergink AP, Arp PP, et al. Association of 5’ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet. 2003;12(14):1745–54.

    Article  Google Scholar 

  7. Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, et al. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res. 2003;18(9):1632–41.

    Article  CAS  Google Scholar 

  8. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, et al. GENOMOS study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004;292(17):2105–14.

    Article  CAS  Google Scholar 

  9. Gallagher JC, Fowler SE, Detter JR, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab. 2001;86(8):3618–28.

    Article  CAS  Google Scholar 

  10. Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, et al. International union of pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev. 2006;58(4):742–59.

    Article  CAS  Google Scholar 

  11. Zmuda JM, Cauley JA. Vitamin D receptor gene variants and osteoporosis. Epidemiol Rev. 2000;22:203–17.

    Article  CAS  Google Scholar 

  12. Ferrari S, Bonjour JP, Rizzoli R. The vitamin D receptor gene and calcium metabolism. Trends Endocrinol Metab. 1998;9(7):259–65.

    Article  CAS  Google Scholar 

  13. Organization of the human vitamin. D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997;11(8):1165–79.

    Article  Google Scholar 

  14. Taymans SE, Pack S, Pak E, Orban Z, Barsony J, Zhuang Z, et al. The human vitamin D receptor gene (VDR) is localized to region 12cen-q12 by fluorescent in situ hybridization and radiation hybrid mapping: genetic and physical VDR map. J Bone Miner Res. 1999;14(7):1163–6.

    Article  CAS  Google Scholar 

  15. Kurabayashi T, Tomita M, Matsushita H, Yahata T, Honda A, Takakuwa K. Association of Vitamin D and estrogen receptor gene polymorphism with effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol. 1999;180:1115–20.

    Article  CAS  Google Scholar 

  16. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284–7.

    Article  CAS  Google Scholar 

  17. Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997;337(2):77–82.

    Article  CAS  Google Scholar 

  18. Gennari L, Becherini L, Masi L, Mansani R, Gonneli S, Cepallaro C, et al. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab. 1998;83(3):933–44.

    Article  Google Scholar 

  19. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP. Vitamin D receptor polymorphisms and change in lumbar spine bone mineral density. Lancet. 1995;345:423–4.

    Article  CAS  Google Scholar 

  20. Kikuchi R, Uemura T, Gorai I, Ohno S, Minaguchi H. Early and late postmenopausal bone loss is associated with BsmI Vitamin D receptor gene polymorphism in Japanese women. Calcif Tissue Int. 1999;64:102–6.

    Article  CAS  Google Scholar 

  21. Mitra S, Desai M, Ikram Khatkhatay M. Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women. Maturitas. 2006;55(1):27–35.

    Article  CAS  Google Scholar 

  22. WHO. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646–50.

    Article  Google Scholar 

  23. Bell TD, Demay MB, Burnett-Bowie SA. The biology and athology of vitamin D control in bone. J Cell Biochem. 2010;111:7–13.

    Article  CAS  Google Scholar 

  24. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr. 2005;81:1232S–9S.

    Article  CAS  Google Scholar 

  25. Pérez A, Ulla M, García B, Lavezzo M, Elías E, Binci M, et al. Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women. J Bone Miner Metab. 2008;26(4):358–65.

    Article  Google Scholar 

  26. Tofteng C, Jenesen J, Abrahamsen B, Odum L, Brot C. Two polymorphisms in the vitamin D receptor gene-association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study. J Bone Miner Res. 2002;17:1535–44.

    Article  CAS  Google Scholar 

  27. Blanchet C, Guiguère Y, Prud′homme D, Dumont M, Rousseau F, Dodin S. Association of physical activity and bone: influence of vitamin D receptor genotype. Med Sci Sports Exerc. 2002;34:24–31.

    Article  CAS  Google Scholar 

  28. Grundberg E, Brändström H, Ribom EL, Ljunggren O, Kindmark A, Mallmin H. A poly adenosine repeat in the human vitamin D receptor gene is associated with bone mineral density in young Swedish women. Calcif Tissue Int. 2003;73(5):455–62.

    Article  CAS  Google Scholar 

  29. Taguchi A, Kobavashi J, Suei Y, Ohtsuka M, Nakamoto T, Tanimoto K, et al. Association of estrogen and vitamin D receptor gene polymorphisms with tooth loss and oral bone loss in Japanese postmenopausal women. Menopause. 2003;10:250–7.

    Article  Google Scholar 

  30. Lisker R, Lopez MA, Jasqui S, De Leon Ponce, Rosales S, Correa- Rotter R, Sanchez S, et al. Association of vitamin D receptor polymorphisms with osteoporosis in Mexican postmenopausal women. Hum Biol. 2003;75:399–403.

    Article  Google Scholar 

  31. Douroudis K, Tarassi G, Ioannidis F, Giannakopoulos P, Moutsatsou N, Thalassinos N, et al. Association of vitamin D receptor gene polymorphisms with bone mineral density in postmenopausal women of Hellenic origin. Maturitas. 2003;45:191–7.

    Article  CAS  Google Scholar 

  32. Chen HY, Chen WC, Hsu CD, Tsai FJ, Tsai CH, Li CW. Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan. Osteoporos Int. 2001;12(12):1036–41.

    Article  CAS  Google Scholar 

  33. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res. 1995;10(6):985–90.

    Article  CAS  Google Scholar 

  34. Hansen T, Abrahamsen B, Henriksen F, Hermann A, Jensen L, Horder M, et al. Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish peremenopausal women. Bone. 1998;22:571–5.

    Article  CAS  Google Scholar 

  35. Bandrés E, Pombo I, González-Huarriz M, Rebollo A, López G, García-Foncillas J. Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women. J Endocrinol Invest. 2005;28:312–21.

    Article  Google Scholar 

  36. Palomba S, Numis FG, Mossetti G, Rendina D, Vuotto P, Russo T, et al. Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes. Hum Reprod. 2003;18(1):192–8.

    Article  CAS  Google Scholar 

  37. Choi YM, Jun JK, Choe J, Hwang D, Park SH, Ku SY, et al. Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean women. J Hum Genet. 2000;45(5):280–3.

    Article  CAS  Google Scholar 

  38. Yasovanthi J, Karunakar KV, Manjari KS, Reddy BP, Kumar PA, Charyulu MS, et al. Association of vitamin D receptor gene polymorphisms with BMD and their effect on 1, 25-dihydroxy vitamin D3 levels in pre-and postmenopausal South Indian women from Andhra Pradesh. Clin Chim Acta. 2011;412(7):541–4.

    Article  CAS  Google Scholar 

  39. Zhang J, Ai Z, Ning X, Liu X, Tang W, Luo Y. The association between vitamin D receptor FokI gene polymorphism and osteoporosis in postmenopausal women: a meta-analysis. J Osteopor Phys Act. 2015;3:143. doi:10.4172/2329-9509.1000143.

    Article  Google Scholar 

  40. Wang D, Liu R, Zhu H, Zhou D, Mei Q, Xu G. Vitamin D receptor Fok I polymorphism is associated with low bone mineral density in postmenopausal women: a meta-analysis focused on populations in Asian countries. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):380–6.

    Article  CAS  Google Scholar 

  41. Ji GR, Yao M, Sun CY, Li ZH, Han Z. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and risk of fracture in Caucasians: a meta-analysis. Bone. 2010;47(3):681–6.

    Article  CAS  Google Scholar 

  42. Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, et al. JPOS Study Group. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study. Int J Epidemiol. 2004;33(5):979–88.

    Article  Google Scholar 

  43. Katzburg S, Hendel D, Waisman A, Posner GH, Kaye AM, Somjen D. Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17 β-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts. J Steroid Biochem Mol Biol. 2004;88(2):213–9.

    Article  CAS  Google Scholar 

  44. Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int. 2004;15(1):56–61.

    Article  CAS  Google Scholar 

  45. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000;72(2):472–5.

    Article  CAS  Google Scholar 

  46. Vupputuri MR, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians. Am J Clin Nutr. 2006;83(6):1411–9.

    Article  CAS  Google Scholar 

  47. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996;11(12):1850–5.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Indian Council of Medical Research (ICMR) [5/4-/5/14Ortho/2011-NCD-I].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abbas Ali Mahdi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmad, I., Jafar, T., Mahdi, F. et al. Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis. Ind J Clin Biochem 33, 429–437 (2018). https://doi.org/10.1007/s12291-017-0706-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-017-0706-x

Keywords

Navigation